Clinical trial · Interventional
Effects of a Combined Program of Pelvic Floor Muscle Training and Yoga
Effects of a Combined Program of Pelvic Floor Muscle Training and Yoga on Relieving Genitourinary Symptoms, and Improving Sexual Function and Quality of Life in Asian Women With Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to examine the effects of Pelvic Floor Muscle Training (PFMT) combined with yoga on relieving genitourinary symptoms, symptom-related quality of life, and improving sexual function in women with breast cancer. This study is a parallel randomized study with two groups. Women will be assigned to the experimental or control group by using the block randomization method. The experimental group will receive regular care and a 12-week program of PFMT and yoga. The control group will receive regular care. We collect relevant data from both groups at baseline and 4, 8, 12, and 24 weeks after baseline during the study period.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Genitourinary Symptoms | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
| Sexual Function | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pelvic Floor Muscle Training (PFMT) and yoga | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- The experimental group will receive regular care and a 12-week program of pelvic floor muscle training (PFMT) and yoga
- interventionNames
- Behavioral: Pelvic Floor Muscle Training (PFMT) and yoga
- type
- NO_INTERVENTION
- label
- Control group
- description
- The control group will receive regular care
Primary outcomes (5)
- measure
- Vulvovaginal Symptoms
- timeFrame
- Baseline
- description
- The 21-item Chinese version of the Vulvovaginal Symptoms Questionnaire (C-VSQ) comprises four subscales to assess vulvovaginal symptoms experienced during the past week (Items 1-7), and symptom-related influences (Emotions Items 8-11; Life-impact Items 12-15, and Sexual-impact Items 16, 18-21). The response options for all items are "Yes" (1 point) and "No" (0 point). Subscale scores are the sum of the scores for the items included in that subscale. The C-VSQ total score is the sum of three subscale scores (0-15 points) or four subscale scores (0-20 points for sexually active women). A higher C-VSQ total score indicates experiencing greater severity of vulvovaginal symptoms and symptom-related influences.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 20-60 years * Women with a confirmed diagnosis of breast cancer (Stages I-III) for ≥3 months * Women who experience ≥1 genitourinary symptom(s) Exclusion Criteria: * Women with other types of cancer diagnoses (e.g., endometrial cancer and ovarian cancer) * Women with inadequately managed chronic conditions (e.g., an individual with diabetes having HbA1c level \>7%)
References
Publications (0)
Data not yet available